CLDI ▼ -6.0% - Calidi Biotherapeutics, Inc. $CLDI - Calidi Biotherapeutics Announces $1.2 Million Registered Direct Offering Calidi Biotherapeutics announced a $1.2 million registered direct offering, which likely pressured the stock as investors digested potential dilution from the capital raise. The 6.0% decline reflects typical market reaction to equity offerings, where existing shareholders face ownership dilution from newly issued shares. 17-SEP-2026 09:10 AM ET